Latest Publications


Biotechnological Management of Skin Burn Injuries: Challenges and Perspectives in Wound Healing and Sensory Recovery. Girard D, Laverdet B, Buhé V, Trouillas M, Ghazi K, Alexaline MM, Egles C, Misery L, Coulomb B, Lataillade JJ, Berthod F, Desmoulière A. Tissue Eng Part B Rev. 2017 Feb;23(1):59-82.

Intravenous Injection of Clinical Grade Human MSCs After Experimental Stroke: Functional Benefit and Microvascular Effect. Moisan A, Favre I, Rome C, De Fraipont F, Grillon E, Coquery N, Mathieu H, Mayan V, Naegele B, Hommel M, Richard MJ, Barbier EL, Remy C, Detante O. Cell Transplant. 2016 Dec 13;25(12):2157-2171. doi: 10.3727/096368916X691132. PMID: 26924704

Clinical-scale expansion of Adipose derived Stromal Cells starting from Stromal Vascular Fraction in a single-use bioreactor: Proof of concept for autologous applications. Gadelorge M, Bourdens M, Espagnolle N, Bardiaux C, Murrell J, Savary L, Ribaud S, Chaput B, Sensebe L. J Tissue Eng Regen Med. 2016 Dec 11.  doi: 10.1002/term.2377. [Epub ahead of print]

Luz-Crawford P, Torres MJ, Noël D, Fernandez A, Alcayaga-Miranda F, Tejedor G, Jorgensen C, Illanes S, Figueroa  FE, Djouad F, Khoury M. The Immunosuppressive Signature of Menstrual Blood Mesenchymal Stem Cells Entails Opposite Effects on Experimental Arthritis and Graft Versus Host Diseases. Stem Cells 2016, 34:456-469.

Luz-Crawford P, Djouad F, Toupet K, Bony C, Franquesa M, Hoogduijn, Jorgensen C, Noël D. Mesenchymal stem cell-derived IL1RA promotes macrophage polarization and inhibits B cell differentiation. Stem cells, 2016, 34:483-482.

Morille M, Toupet K, Montero-Menei C N, Jorgensen C, Noël D. PLGA-based microcarriers induce mesenchymal stem cell chondrogenesis and stimulate cartilage repair in osteoarthritis. Biomaterials 2016, 88:60-69.

Maria A, Toupet K, Bony C, Pirot N, Vozenin M-C, Benoit P, Roger P, Batteux F, Le Quellec A, Jorgensen C, Guilpain P, Noël D. Anti-fibrotic, anti-oxydant and immunomodulatory effects of mesenchymal stem cells in HOCl-induced systemic sclerosis. Arthritis Rheum 2016; 68:1013-1025.

Maria A, Toupet K, Maumus M, Fonteneau G, Le Quellec A, Jorgensen C, Guilpain P, Noël D. Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis. J. Autoimmunity 2016; 70:31-39

Domergue S, Bony C, Maumus M, Toupet K, Frouin E, Rigau V, Vozenin M-C, Magalon G, Jorgensen C, Noël D. Comparison between stromal vascular fraction and adipose mesenchymal stem cells in remodeling hypertrophic scars. PLoSONE, 2016, 11:e0156161.

Pers Y-M, Rackwitz L, Ferreira R, Pullig O, Delfour C, Barry F, Sensébé L, Casteilla L, Fleury S, Bourin P, Noël D, Canovas F, Cyteval C, Lisignoli G, Schrauth J, Haddad D, Domergue S, Noeth U, Jorgensen C. Adipose mesenchymal stem cell-based therapy for severe osteoarthritis of the knee: A phase I dose escalation trial. Stem Cell Transl. Med 2016, 5:847-856.

Maumus M, Roussignol G, Toupet K,Penarier G, Bentz I, Teixeira S, Oustric D, Jung M, Lepage O, Steinberg R, Jorgensen C, Noël D. Utility of a mouse model of osteoarthritis to demonstrate cartilage protection by IFN-γ primed equine

- Loisel S, Dulong J, Ménard C, Renoud ML, Meziere N, Isabelle B, Latour M, Bescher N, Pedeux R, Bertheuil N, Flecher E, Sensebé L, Tarte K. Proteasomal IDO degradation reduces the immunosuppressive potential of clinical grade-mesenchymal stromal cells undergoing replicative senescence. Stem Cells. 2017 Jan 31. doi: 10.1002/stem.2580.

- Bigot N, Sensebé L, Tarte K, Pedeux R. Reply: Standardized procedure for bone marrow MSCs preparation for clinical use. Stem Cells. 2016 34:1994-5. Letter.


All Publications


Biotechnological Management of Skin Burn Injuries: Challenges and Perspectives in Wound Healing and Sensory Recovery. Girard D, Laverdet B, Buhé V, Trouillas M, Ghazi K, Alexaline MM, Egles C, Misery L, Coulomb B, Lataillade JJ, Berthod F, Desmoulière A. Tissue Eng Part B Rev. 2017 Feb;23(1):59-82.

Intravenous Injection of Clinical Grade Human MSCs After Experimental Stroke: Functional Benefit and Microvascular Effect. Moisan A, Favre I, Rome C, De Fraipont F, Grillon E, Coquery N, Mathieu H, Mayan V, Naegele B, Hommel M, Richard MJ, Barbier EL, Remy C, Detante O. Cell Transplant. 2016 Dec 13;25(12):2157-2171. doi: 10.3727/096368916X691132. PMID: 26924704

Clinical-scale expansion of Adipose derived Stromal Cells starting from Stromal Vascular Fraction in a single-use bioreactor: Proof of concept for autologous applications. Gadelorge M, Bourdens M, Espagnolle N, Bardiaux C, Murrell J, Savary L, Ribaud S, Chaput B, Sensebe L. J Tissue Eng Regen Med. 2016 Dec 11.  doi: 10.1002/term.2377. [Epub ahead of print]

Luz-Crawford P, Torres MJ, Noël D, Fernandez A, Alcayaga-Miranda F, Tejedor G, Jorgensen C, Illanes S, Figueroa  FE, Djouad F, Khoury M. The Immunosuppressive Signature of Menstrual Blood Mesenchymal Stem Cells Entails Opposite Effects on Experimental Arthritis and Graft Versus Host Diseases. Stem Cells 2016, 34:456-469.

Luz-Crawford P, Djouad F, Toupet K, Bony C, Franquesa M, Hoogduijn, Jorgensen C, Noël D. Mesenchymal stem cell-derived IL1RA promotes macrophage polarization and inhibits B cell differentiation. Stem cells, 2016, 34:483-482.

Morille M, Toupet K, Montero-Menei C N, Jorgensen C, Noël D. PLGA-based microcarriers induce mesenchymal stem cell chondrogenesis and stimulate cartilage repair in osteoarthritis. Biomaterials 2016, 88:60-69.

Maria A, Toupet K, Bony C, Pirot N, Vozenin M-C, Benoit P, Roger P, Batteux F, Le Quellec A, Jorgensen C, Guilpain P, Noël D. Anti-fibrotic, anti-oxydant and immunomodulatory effects of mesenchymal stem cells in HOCl-induced systemic sclerosis. Arthritis Rheum 2016; 68:1013-1025.

Maria A, Toupet K, Maumus M, Fonteneau G, Le Quellec A, Jorgensen C, Guilpain P, Noël D. Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis. J. Autoimmunity 2016; 70:31-39

Domergue S, Bony C, Maumus M, Toupet K, Frouin E, Rigau V, Vozenin M-C, Magalon G, Jorgensen C, Noël D. Comparison between stromal vascular fraction and adipose mesenchymal stem cells in remodeling hypertrophic scars. PLoSONE, 2016, 11:e0156161.

Pers Y-M, Rackwitz L, Ferreira R, Pullig O, Delfour C, Barry F, Sensébé L, Casteilla L, Fleury S, Bourin P, Noël D, Canovas F, Cyteval C, Lisignoli G, Schrauth J, Haddad D, Domergue S, Noeth U, Jorgensen C. Adipose mesenchymal stem cell-based therapy for severe osteoarthritis of the knee: A phase I dose escalation trial. Stem Cell Transl. Med 2016, 5:847-856.

Maumus M, Roussignol G, Toupet K,Penarier G, Bentz I, Teixeira S, Oustric D, Jung M, Lepage O, Steinberg R, Jorgensen C, Noël D. Utility of a mouse model of osteoarthritis to demonstrate cartilage protection by IFN-γ primed equine

- Loisel S, Dulong J, Ménard C, Renoud ML, Meziere N, Isabelle B, Latour M, Bescher N, Pedeux R, Bertheuil N, Flecher E, Sensebé L, Tarte K. Proteasomal IDO degradation reduces the immunosuppressive potential of clinical grade-mesenchymal stromal cells undergoing replicative senescence. Stem Cells. 2017 Jan 31. doi: 10.1002/stem.2580.

- Bigot N, Sensebé L, Tarte K, Pedeux R. Reply: Standardized procedure for bone marrow MSCs preparation for clinical use. Stem Cells. 2016 34:1994-5. Letter.

Attyé, A., Villien, M., Tahon, F., Warnking, J., Detante, O., and Krainik, A. (2014). Normalization of cerebral vasoreactivity using BOLD MRI after intravascular stenting. Hum Brain Mapp 35, 1320–1324.

- Barkholt, L., Flory, E., Jekerle, V., Lucas-Samuel, S., Ahnert, P., Bisset, L., Büscher, D., Fibbe, W., Foussat, A., Kwa, M., et al. (2013). Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints. Cytotherapy 15, 753–759.

- Bassi, G., Guilloton, F., Menard, C., Di Trapani, M., Deschaseaux, F., Sensebé, L., Schrezenmeier, H., Giordano, R., Bourin, P., Dominici, M., et al. (2015). Effects of a ceramic biomaterial on immune modulatory properties and differentiation potential of human mesenchymal stromal cells of different origin. Tissue Eng Part A 21, 767–781.

- Bertheuil, N., Chaput, B., Ménard, C., Varin, A., Garrido, I., Grolleau, J.L., Sensébé, L., Watier, E., and Tarte, K. (2015). [Adipose-derived stromal cells: history, isolation, immunomodulatory properties and clinical perspectives]. Ann Chir Plast Esthet 60, 94–102.

- Bigot, N., Mouche, A., Preti, M., Loisel, S., Renoud, M.-L., Le Guével, R., Sensebé, L., Tarte, K., and Pedeux, R. (2015a). Hypoxia Differentially Modulates the Genomic Stability of Clinical-Grade ADSCs and BM-MSCs in Long-Term Culture. Stem Cells 33, 3608–3620.

- Bigot, N., Guérillon, C., Loisel, S., Bertheuil, N., Sensebé, L., Tarte, K., and Pedeux, R. (2015b). ING1b negatively regulates HIF1α protein levels in adipose-derived stromal cells by a SUMOylation-dependent mechanism. Cell Death Dis 6, e1612.

- Bouacida, A., Rosset, P., Trichet, V., Guilloton, F., Espagnolle, N., Cordonier, T., Heymann, D., Layrolle, P., Sensébé, L., and Deschaseaux, F. (2012). Pericyte-like progenitors show high immaturity and engraftment potential as compared with mesenchymal stem cells. PLoS ONE 7, e48648.

- Bura, A., Planat-Benard, V., Bourin, P., Silvestre, J.-S., Gross, F., Grolleau, J.-L., Saint-Lebese, B., Peyrafitte, J.-A., Fleury, S., Gadelorge, M., et al. (2014). Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia. Cytotherapy 16, 245–257.

- Caicedo, A., Fritz, V., Brondello, J.-M., Ayala, M., Dennemont, I., Abdellaoui, N., de Fraipont, F., Moisan, A., Prouteau, C.A., Boukhaddaoui, H., et al. (2015). MitoCeption as a new tool to assess the effects of mesenchymal stem/stromal cell mitochondria on cancer cell metabolism and function. Sci Rep 5, 9073.

- Chabot, V., Dromard, C., Rico, A., Langonné, A., Gaillard, J., Guilloton, F., Casteilla, L., and Sensebé, L. (2015). Urokinase-type plasminogen activator receptor interaction with β1 integrin is required for platelet-derived growth factor-AB-induced human mesenchymal stem/stromal cell migration. Stem Cell Res Ther 6, 188.

- Cordonnier, T., Langonné, A., Corre, P., Renaud, A., Sensebé, L., Rosset, P., Layrolle, P., and Sohier, J. (2014). Osteoblastic differentiation and potent osteogenicity of three-dimensional hBMSC-BCP particle constructs. J Tissue Eng Regen Med 8, 364–376.

- Cras, A., Farge, D., Carmoi, T., Lataillade, J.-J., Wang, D.D., and Sun, L. (2015). Update on mesenchymal stem cell-based therapy in lupus and scleroderma. Arthritis Res. Ther. 17, 301.

- Deschaseaux, F., Gaillard, J., Langonné, A., Chauveau, C., Naji, A., Bouacida, A., Rosset, P., Heymann, D., De Pinieux, G., Rouas-Freiss, N., et al. (2013). Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue. FASEB J. 27, 2977–2987.

- Detante, O., Moisan, A., Dimastromatteo, J., Richard, M.-J., Riou, L., Grillon, E., Barbier, E., Desruet, M.-D., De Fraipont, F., Segebarth, C., et al. (2009). Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution. Cell Transplant 18, 1369–1379.

- Detante, O., Jaillard, A., Moisan, A., Barbieux, M., Favre, I.M., Garambois, K., Hommel, M., and Remy, C. (2014). Biotherapies in stroke. Rev. Neurol. (Paris) 170, 779–798.

- Domergue, S., Jorgensen, C., and Noël, D. (2015). Advances in Research in Animal Models of Burn-Related Hypertrophic Scarring. J Burn Care Res 36, e259–e266.

- Duroux-Richard, I., Cuenca, J., Ponsolles, C., Piñeiro, A.B., Gonzalez, F., Roubert, C., Areny, R., Chea, R., Pefaur, J., Pers, Y.-M., et al. (2015). MicroRNA Profiling of B Cell Subsets from Systemic Lupus Erythematosus Patients Reveals Promising Novel Biomarkers. Int J Mol Sci 16, 16953–16965.

- Escobar, P., Bouclier, C., Serret, J., Bièche, I., Brigitte, M., Caicedo, A., Sanchez, E., Vacher, S., Vignais, M.-L., Bourin, P., et al. (2015). IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production. Oncotarget 6, 29034–29047.

- Espagnolle, N., Guilloton, F., Deschaseaux, F., Gadelorge, M., Sensébé, L., and Bourin, P. (2014). CD146 expression on mesenchymal stem cells is associated with their vascular smooth muscle commitment. J. Cell. Mol. Med. 18, 104–114.

- Fekete, N., Gadelorge, M., Fürst, D., Maurer, C., Dausend, J., Fleury-Cappellesso, S., Mailänder, V., Lotfi, R., Ignatius, A., Sensebé, L., et al. (2012). Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components. Cytotherapy 14, 540–554.

- Fekete, N., Erle, A., Amann, E.M., Fürst, D., Rojewski, M.T., Langonné, A., Sensebé, L., Schrezenmeier, H., and Schmidtke-Schrezenmeier, G. (2015). Effect of high-dose irradiation on human bone-marrow-derived mesenchymal stromal cells. Tissue Eng Part C Methods 21, 112–122.

- Guérit, D., Philipot, D., Chuchana, P., Toupet, K., Brondello, J.-M., Mathieu, M., Jorgensen, C., and Noël, D. (2013). Sox9-regulated miRNA-574-3p inhibits chondrogenic differentiation of mesenchymal stem cells. PLoS ONE 8, e62582.

- Guérit, D., Brondello, J.-M., Chuchana, P., Philipot, D., Toupet, K., Bony, C., Jorgensen, C., and Noël, D. (2014). FOXO3A regulation by miRNA-29a Controls chondrogenic differentiation of mesenchymal stem cells and cartilage formation. Stem Cells Dev. 23, 1195–1205.

- ter Huurne, M., Schelbergen, R., Blattes, R., Blom, A., de Munter, W., Grevers, L.C., Jeanson, J., Noël, D., Casteilla, L., Jorgensen, C., et al. (2012). Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis. Arthritis Rheum. 64, 3604–3613.

- Krampera, M., Galipeau, J., Shi, Y., Tarte, K., Sensebe, L., and MSC Committee of the International Society for Cellular Therapy (ISCT) (2013). Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal. Cytotherapy 15, 1054–1061.

- Leroy, A., Nottelet, B., Bony, C., Pinese, C., Charlot, B., Garric, X., Noël, D., and Coudane, J. (2015). PLA-poloxamer/poloxamine copolymers for ligament tissue engineering: sound macromolecular design for degradable scaffolds and MSC differentiation. Biomater Sci 3, 617–626.

- Linard, C., Tissedre, F., Busson, E., Holler, V., Leclerc, T., Strup-Perrot, C., Couty, L., L’homme, B., Benderitter, M., Lafont, A., et al. (2015). Therapeutic potential of gingival fibroblasts for cutaneous radiation syndrome: comparison to bone marrow-mesenchymal stem cell grafts. Stem Cells Dev. 24, 1182–1193.

- Lopez-Mejia, I.C., De Toledo, M., Della Seta, F., Fafet, P., Rebouissou, C., Deleuze, V., Blanchard, J.M., Jorgensen, C., Tazi, J., and Vignais, M.-L. (2013). Tissue-specific and SRSF1-dependent splicing of fibronectin, a matrix protein that controls host cell invasion. Mol. Biol. Cell 24, 3164–3176.

- Luz-Crawford, P., Noël, D., Fernandez, X., Khoury, M., Figueroa, F., Carrión, F., Jorgensen, C., and Djouad, F. (2012). Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway. PLoS ONE 7, e45272.

- Luz-Crawford, P., Kurte, M., Bravo-Alegría, J., Contreras, R., Nova-Lamperti, E., Tejedor, G., Noël, D., Jorgensen, C., Figueroa, F., Djouad, F., et al. (2013). Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther 4, 65.

- Luz-Crawford, P., Tejedor, G., Mausset-Bonnefont, A.L., Beaulieu, E., Morand, E.F., Jorgensen, C., Noël, D., and Djouad, F. (2015). Glucocorticoid-induced leucine zipper governs the therapeutic potential of mesenchymal stem cells by inducing a switch from pathogenic to regulatory Th17 cells in a mouse model of collagen-induced arthritis. Arthritis & Rheumatology (Hoboken, N.J.) 67, 1514–1524.

- Luz-Crawford, P., Djouad, F., Toupet, K., Bony, C., Franquesa, M., Hoogduijn, M.J., Jorgensen, C., and Noël, D. (2016a). Mesenchymal Stem Cell-Derived Interleukin 1 Receptor Antagonist Promotes Macrophage Polarization and Inhibits B Cell Differentiation. Stem Cells 34, 483–492.

- Luz-Crawford, P., Torres, M.J., Noël, D., Fernandez, A., Toupet, K., Alcayaga-Miranda, F., Tejedor, G., Jorgensen, C., Illanes, S.E., Figueroa, F.E., et al. (2016b). The immunosuppressive signature of menstrual blood mesenchymal stem cells entails opposite effects on experimental arthritis and graft versus host diseases. Stem Cells 34, 456–469.

- Manferdini, C., Maumus, M., Gabusi, E., Paolella, F., Grassi, F., Jorgensen, C., Fleury-Cappellesso, S., Noël, D., and Lisignoli, G. (2015). Lack of anti-inflammatory and anti-catabolic effects on basal inflamed osteoarthritic chondrocytes or synoviocytes by adipose stem cell-conditioned medium. Osteoarthr. Cartil. 23, 2045–2057.

- Maninchedda, U., Lepage, O.M., Gangl, M., Hilairet, S., Remandet, B., Meot, F., Penarier, G., Segard, E., Cortez, P., Jorgensen, C., et al. (2015). Development of an equine groove model to induce metacarpophalangeal osteoarthritis: a pilot study on 6 horses. PLoS ONE 10, e0115089.

- Margossian, P., Mariani, P., Stephan, G., Margerit, J., and Jorgensen, C. (2012). Immediate loading of mandibular dental implants in partially edentulous patients: a prospective randomized comparative study. Int J Periodontics Restorative Dent 32, e51–e58.

- Maria, A.T., Toupet, K., Bony, C., Pirot, N., Vozenin, M.-C., Petit, B., Roger, P., Batteux, F., Le Quellec, A., Jorgensen, C., et al. (2015). Anti-fibrotic, anti-oxidant and immunomodulatory effects of mesenchymal stem cells in HOCl-induced systemic sclerosis. Arthritis & Rheumatology (Hoboken, N.J.).

- Martinaud, C., Desterke, C., Konopacki, J., Pieri, L., Torossian, F., Golub, R., Schmutz, S., Anginot, A., Guerton, B., Rochet, N., et al. (2015a). Osteogenic Potential of Mesenchymal Stromal Cells Contributes to Primary Myelofibrosis. Cancer Res. 75, 4753–4765.

- Martinaud, C., Desterke, C., Konopacki, J., Vannucchi, A.M., Pieri, L., Guglielmelli, P., Dupriez, B., Ianotto, J.-C., Boutin, L., Lataillade, J.-J., et al. (2015b). Transcriptome analysis of bone marrow mesenchymal stromal cells from patients with primary myelofibrosis. Genom Data 5, 1–2.

- Mathieu, M., Vigier, S., Labour, M.N., Jorgensen, C., Belamie, E., and Noël, D. (2014a). Induction of mesenchymal stem cell differentiation and cartilage formation by cross-linker-free collagen microspheres. Eur Cell Mater 28, 82–96; discussion 96–97.

- Mathieu, M., Iampietro, M., Chuchana, P., Guérit, D., Djouad, F., Noël, D., and Jorgensen, C. (2014b). Involvement of angiopoietin-like 4 in matrix remodeling during chondrogenic differentiation of mesenchymal stem cells. J. Biol. Chem. 289, 8402–8412.

- Maumus, M., Manferdini, C., Toupet, K., Peyrafitte, J.-A., Ferreira, R., Facchini, A., Gabusi, E., Bourin, P., Jorgensen, C., Lisignoli, G., et al. (2013a). Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis. Stem Cell Res 11, 834–844.

- Maumus, M., Jorgensen, C., and Noël, D. (2013b). Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes. Biochimie 95, 2229–2234.

- Menard, C., Pacelli, L., Bassi, G., Dulong, J., Bifari, F., Bezier, I., Zanoncello, J., Ricciardi, M., Latour, M., Bourin, P., et al. (2013). Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls. Stem Cells Dev. 22, 1789–1801.

- Moisan, A., Pannetier, N., Grillon, E., Richard, M.-J., de Fraipont, F., Rémy, C., Barbier, E.L., and Detante, O. (2012). Intracerebral injection of human mesenchymal stem cells impacts cerebral microvasculature after experimental stroke: MRI study. NMR Biomed 25, 1340–1348.

- Moisan, A., Favre, I., Rome, C., De Fraipont, F., Grillon, E., Coquery, N., Mathieu, H., Mayan, V., Naegele, B., Hommel, M., et al. (2016). Intravenous injection of clinical grade human MSCs after experimental stroke: functional benefit and microvascular effect. Cell Transplant.

- Montespan, F., Deschaseaux, F., Sensébé, L., Carosella, E.D., and Rouas-Freiss, N. (2014). Osteodifferentiated mesenchymal stem cells from bone marrow and adipose tissue express HLA-G and display immunomodulatory properties in HLA-mismatched settings: implications in bone repair therapy. J Immunol Res 2014, 230346.

- Naji, A., Rouas-Freiss, N., Durrbach, A., Carosella, E.D., Sensébé, L., and Deschaseaux, F. (2013). Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy. Stem Cells 31, 2296–2303.

- Norambuena, G.A., Khoury, M., and Jorgensen, C. (2012). Mesenchymal stem cells in osteoarticular pediatric diseases: an update. Pediatr. Res. 71, 452–458.

- Peltzer, J., Montespan, F., Thepenier, C., Boutin, L., Uzan, G., Rouas-Freiss, N., and Lataillade, J.-J. (2015). Heterogeneous functions of perinatal mesenchymal stromal cells require a preselection before their banking for clinical use. Stem Cells Dev. 24, 329–344.

- Pers, Y.-M., Cadart, D., Rittore, C., Ravel, P., Daïen, V., Fabre, S., Jorgensen, C., and Touitou, I. (2014). TNFRII polymorphism is associated with response to TNF blockers in rheumatoid arthritis patients seronegative for ACPA. Joint Bone Spine 81, 370–372.

- Pers, Y.-M., Ruiz, M., Noël, D., and Jorgensen, C. (2015). Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives. Osteoarthr. Cartil. 23, 2027–2035.

- Phinney, D.G., and Sensebé, L. (2013). Mesenchymal stromal cells: misconceptions and evolving concepts. Cytotherapy 15, 140–145.

- Phinney, D.G., Galipeau, J., Krampera, M., Martin, I., Shi, Y., and Sensebe, L. (2013). MSCs: science and trials. Nat. Med. 19, 812.

- Présumey, J., Courties, G., Louis-Plence, P., Escriou, V., Scherman, D., Pers, Y.-M., Yssel, H., Pène, J., Kyburz, D., Gay, S., et al. (2013). Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis. Ann. Rheum. Dis. 72, 1717–1724.

- Rojewski, M.T., Fekete, N., Baila, S., Nguyen, K., Fürst, D., Antwiler, D., Dausend, J., Kreja, L., Ignatius, A., Sensebé, L., et al. (2013). GMP-compliant isolation and expansion of bone marrow-derived MSCs in the closed, automated device quantum cell expansion system. Cell Transplant 22, 1981–2000.

- Ruiz, M., Cosenza, S., Maumus, M., Jorgensen, C., and Noël, D. (2016). Therapeutic application of mesenchymal stem cells in osteoarthritis. Expert Opin Biol Ther 16, 33–42.

- Schelbergen, R.F., van Dalen, S., ter Huurne, M., Roth, J., Vogl, T., Noël, D., Jorgensen, C., van den Berg, W.B., van de Loo, F.A., Blom, A.B., et al. (2014). Treatment efficacy of adipose-derived stem cells in experimental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levels. Osteoarthr. Cartil. 22, 1158–1166.

- Sensebé, L. (2013). Beyond genetic stability of mesenchymal stromal cells. Cytotherapy 15, 1307–1308.

- Sensebé, L., and Fleury-Cappellesso, S. (2013). Biodistribution of mesenchymal stem/stromal cells in a preclinical setting. Stem Cells Int 2013, 678063.

- Sensebé, L., Tarte, K., Galipeau, J., Krampera, M., Martin, I., Phinney, D.G., Shi, Y., and MSC Committee of the International Society for Cellular Therapy (2012). Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells. Cell Stem Cell 10, 9–10; author reply 10–11.

- Sensebé, L., Gadelorge, M., and Fleury-Cappellesso, S. (2013). Production of mesenchymal stromal/stem cells according to good manufacturing practices: a review. Stem Cell Res Ther 4, 66.

- Spoerl, D., Pers, Y.-M., and Jorgensen, C. (2012). Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: two case reports and review of literature. Allergy Asthma Clin Immunol 8, 19.

- Tîlmaciu, C.-M., Mathieu, M., Lavigne, J.-P., Toupet, K., Guerrero, G., Ponche, A., Amalric, J., Noël, D., and Mutin, P.H. (2015). In vitro and in vivo characterization of antibacterial activity and biocompatibility: a study on silver-containing phosphonate monolayers on titanium. Acta Biomater 15, 266–277.

- Toupet, K., Maumus, M., Peyrafitte, J.-A., Bourin, P., van Lent, P.L.E.M., Ferreira, R., Orsetti, B., Pirot, N., Casteilla, L., Jorgensen, C., et al. (2013). Long-term detection of human adipose-derived mesenchymal stem cells after intraarticular injection in SCID mice. Arthritis Rheum. 65, 1786–1794.

- Toupet, K., Maumus, M., Luz-Crawford, P., Lombardo, E., Lopez-Belmonte, J., van Lent, P., Garin, M.I., van den Berg, W., Dalemans, W., Jorgensen, C., et al. (2015). Survival and biodistribution of xenogenic adipose mesenchymal stem cells is not affected by the degree of inflammation in arthritis. PLoS ONE 10, e0114962.

- Tran Mau-Them, F., Boualam, A., Barat-Houari, M., Jeandel, C., Cottalorda, J., Cormier-Daire, V., Fabre, A., Dumont, B., Lefort, G., Baujat, G., et al. (2014). Dysspondyloenchondromatosis without COL2A1 mutation: possible genetic heterogeneity. Am. J. Med. Genet. A 164A, 769–773.

- Varin, A., Pontikoglou, C., Labat, E., Deschaseaux, F., and Sensebé, L. (2013). CD200R/CD200 inhibits osteoclastogenesis: new mechanism of osteoclast control by mesenchymal stem cells in human. PLoS ONE 8, e72831.

- Veronesi, E., Murgia, A., Caselli, A., Grisendi, G., Piccinno, M.S., Rasini, V., Giordano, R., Montemurro, T., Bourin, P., Sensebé, L., et al. (2014). Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration. Tissue Eng Part C Methods 20, 239–251.

- Viateau, V., Manassero, M., Sensébé, L., Langonné, A., Marchat, D., Logeart-Avramoglou, D., Petite, H., and Bensidhoum, M. (2016). Comparative study of the osteogenic ability of four different ceramic constructs in an ectopic large animal model. J Tissue Eng Regen Med 10, E177–E187.

-